Article

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids

2020-05-05

Abstract excerpt

<h4>Summary Paragraph</h4> The SARS-CoV-2 virus has caused already over 3.5 million COVID-19 cases and 250,000 deaths globally. There is an urgent need to create novel models to study SARS-CoV-2 using human disease-relevant cells to understand key features of virus biology and facilitate drug screening. As primary SARS-CoV-2 infection is respiratory-based, we developed a lung organoid model using human pluripoten...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a726951c-49f5-5dc4-bef5-1acb9d65cf1b
DOI: 10.1101/2020.05.05.079095

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsDOI 10.1101/2020.05.05.079095Read

Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19Semantic proximity Read

Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19Semantic proximity Read

Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infectionSemantic proximity Read

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Semantic proximity Read

Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factorsSemantic proximity Read

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal OrganoidsSemantic proximity Read

Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral OrganoidsSemantic proximity Read

Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue CellsSemantic proximity Read

SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory ResponseSemantic proximity Read

Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infectionSemantic proximity Read

A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infectionSemantic proximity Read

Surfactant deficiency increases SARS-CoV-2 canonical and non-canonical viral entry to lung epithelial cells and exacerbates intrapulmonary inflammatory responsesSemantic proximity Read